Figure 4.

Mean efficacy variable scores for gabapentin versus placebo during and after treatment. Dose was escalated from days 1–6 and reduced from days 78–83. Treatment was stopped completely by visit 4 (dotted line). p values represent the significance of the differences between gabapentin and placebo.